U.S. market Closed. Opens in 1 day 14 hours 15 minutes

PSTV | Plus Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-31
Revenue4.91M224.00KN/A303.00K7.00M2.98M6.41M11.38M11.66M7.60M12.20M14.50M7.98M10.63M14.73M4.53M6.05M7.93M5.63M6.82M14.09M9.17M5.65M6.25M1.51MN/A
Cost of Revenue9.69M712.00K66.00K2.70M5.37M1.15M1.32M2.71M3.19M2.94M3.42M4.00M3.84M3.91M3.39M1.85M422.00K1.63M3.15M3.38M4.24M3.17M4.15M2.39M486.00KN/A
Gross Profit-4.78M-488.00K-66.00K-2.40M1.63M1.83M5.09M8.66M8.47M4.66M8.78M10.50M4.15M6.72M11.34M2.67M5.63M6.29M2.48M3.43M9.84M6.00M1.50M3.86M1.03MN/A
Operating Expenses8.54M19.94M12.43M9.89M10.65M11.74M25.78M28.37M31.43M37.46M42.12M38.79M37.92M32.04M32.88M32.44M31.72M25.67M30.48M19.39M19.05M17.50M14.68M13.47M5.50M2.06M
Selling, General & Admin8.54M10.24M6.85M6.41M5.29M6.22M11.19M12.17M12.43M22.36M25.06M25.16M28.29M23.61M17.00M16.33M16.86M14.60M15.58M8.34M9.00M7.94M8.07M5.18M3.67M806.00K
Research & Development9.69M9.70M5.57M3.48M5.37M5.52M13.36M16.20M19.00M15.11M17.07M13.63M10.90M9.69M12.23M15.05M20.02M21.98M15.64M11.01M9.07M7.90M5.49M2.58M1.17M1.18M
Other Operating Expenses-9.69M1.00K6.00K781.00K-1.23M-470.00K1.23MN/AN/AN/AN/AN/A-1.27M-1.25M3.65M1.06M-5.16M-10.91M-742.00K42.00K985.00K1.66M1.12M5.70M661.00K76.00K
Operating Income-13.32M-19.71M-12.49M-9.58M-3.66M-8.76M-20.68M-19.71M-22.95M-32.81M-33.35M-28.29M-33.77M-25.32M-21.55M-29.76M-26.09M-19.38M-28.00M-15.96M-9.21M-11.50M-13.18M-9.61M-4.47M-2.06M
Other Expenses / Income5.00K-563.00K-907.00K1.34M374.00K1.76M-2.00M-2.34M4.21M-4.56M7.17M-3.99M4.10M-128.00K-262.00K-1.15M1.71M4.33M2.04M13.75M-490.00K-882.00K-104.00KN/AN/AN/A
Before Tax Income-13.32M-20.27M-13.40M-8.24M-3.28M-8.88M-22.69M-22.05M-18.74M-37.37M-26.18M-32.28MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax ExpensesN/A563.00K932.00K1.11M9.46M1.99MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-13.32M-20.84M-14.33M-9.35M-12.74M-12.63M-22.69M-22.05M-18.74M-37.37M-26.18M-32.28M-32.45M-27.49M-23.22M-30.04M-28.67M-25.45M-26.54M-2.09M-9.28M-13.00M-11.21M-8.64M-4.57M-2.09M
Interest Expenses395.00K711.00K932.00K1.11M1.85M1.92M2.05M2.59M3.38M4.37M3.40M3.39M2.78M2.05M1.43M420.00K155.00K199.00K137.00K177.00KN/A263.00K168.00K351.00KN/A43.00K
Basic Shares Outstanding3.14M1.75M805.95K295.19K92.27K11.59K64.78K34.58K19.72K11.32K9.49K8.22K7.49K6.43K5.03K3.76K3.21K2.33K2.06K1.95K2.04K2.05K2.09K1.15K2.10K2.10K
Diluted Shares Outstanding3.14M1.75M805.95K295.19K92.27K11.59K64.78K34.58K19.72K11.32K9.49K8.22K7.49K6.43K5.03K3.76K3.21K2.33K2.06K2.07K2.04K2.05K2.09K1.15K2.10K2.10K
EBITDA-12.69M-18.95M-12.01M-9.17M-2.71M-6.71M-18.49M-18.27M-14.27M-32.22M-21.15M-27.96M-28.81M-24.51M-20.11M-27.91M-26.90M-23.13M-24.68M-1.09M-7.63M-11.27M-9.86M-7.85M-4.57M-2.06M
EBITDA Margin-258.36%-8,458.04%0.00%-3,025.74%-38.67%-225.11%-288.35%-160.56%-122.41%-424.03%-173.43%-192.81%-360.92%-230.65%-136.51%-616.28%-444.72%-291.76%-438.00%-15.97%-54.13%-122.94%-174.49%-125.63%-302.12%0.00%
EBIT-12.92M-19.56M-12.47M-7.13M-1.43M-8.73M-20.64M-19.45M-15.37M-33.00M-22.78M-28.89M-29.67M-25.44M-21.79M-29.62M-28.52M-25.25M-26.40M-1.91M-9.28M-12.74M-11.04M-8.29M-4.57M-2.05M
EBIT Margin-263.00%-8,733.93%0.00%-2,354.46%-20.41%-292.52%-321.90%-170.95%-131.79%-434.29%-186.79%-199.25%-371.63%-239.41%-147.92%-654.06%-471.43%-318.51%-468.60%-28.06%-65.89%-138.99%-195.45%-132.68%-302.12%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙